CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Treatment with Telaprevir/PEG-IFN/RBV after 14-day Telaprevir exposure in phase I studies: Results from the phase IIIB C219 rollover study
DOI 10.1055/s-0033-1352806
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Sarrazin, HW Reesink, S Zeuzem, I Dierynck, D Luo, J Witek, G Picchio, S De Meyer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and aims: C219 (NCT01054573) was an open-label, single-arm, rollover study that examined telaprevir (TVR)-based therapy in patients infected with chronic genotype 1 HCV who failed to achieve a sustained virologic response (SVR) following peginterferon/ribavirin (PR) alone in the REALIZE study, or with ≥1 dose of TVR (alone or in combination with PR) in Phase I studies (101 and 103). Here we present the pr…
Zitieren
Zitierempfehlung
C Sarrazin, HW Reesink, S Zeuzem, I Dierynck, D Luo, J Witek, G Picchio, S De Meyer (2013) Treatment with Telaprevir/PEG-IFN/RBV after 14-day Telaprevir exposure in phase I studies: Results from the phase IIIB C219 rollover study. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0033-1352806
Mit CareLit weiterarbeiten